Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,152.44
+14.621.28%
Post-market: 1,150.66-1.7800-0.15%19:59 EDT
Volume:1.90M
Turnover:2.18B
Market Cap:1.09T
PE:38.69
High:1,159.75
Open:1,150.27
Low:1,138.26
Close:1,137.82
52wk High:1,292.65
52wk Low:712.05
Shares:945.38M
Float Shares:939.00M
Volume Ratio:1.02
T/O Rate:0.20%
Dividend:6.69
Dividend Rate:0.58%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:32.16
PE(LYR):50.22

Loading ...

Eli Lilly: We Will Continue to Focus on the Science and Defend Against Novo Nordisk Lawsuit Vigorously

THOMSON REUTERS
·
Jul 21

Eli Lilly Faces Lawsuit Over Weight-Loss Drug Ads! Accused By Novo Nordisk Of "Misleading Marketing"

Sector Pulse
·
Jul 21

U.S. Stocks on the Move-utz Brands, Tutor Perini, Tripadvisor

Reuters
·
Jul 21

Eli Lilly Faces Legal Action from Novo Nordisk Over Alleged Misleading Weight-Loss Drug Advertisements

Stock News
·
Jul 21

Novo Nordisk Says Mismatched Diabetes Drug Ads Triggered Lawsuit Vs. Lilly

Dow Jones
·
Jul 21

Novo Sues Lilly, Claiming Misleading Ads in Weight-loss Drug Battle

Reuters
·
Jul 21

Novo Nordisk files lawsuit against ‘misleading’ GLP-1 ads from Eli Lilly

TIPRANKS
·
Jul 21

Novo Nordisk Sues Eli Lilly Over Zepbound, Mounjaro Advertising

MT Newswires Live
·
Jul 21

Novo Nordisk Sues Eli Lilly Over Allegedly Misleading GLP-1 Advertising

MT Newswires Live
·
Jul 21

Novo Nordisk Sues Eli Lilly in U.S. Federal Court, Alleging Claim Under the Lanham Act, Court Records Show

THOMSON REUTERS
·
Jul 21

South Africa Regulator Reviews 12 Generic Semaglutide Applications

Reuters
·
Jul 21

Eli Lilly & Co. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 21

Eli Lilly May Raise Stake in Scribe Therapeutics to 10.9% Stake Through IPO

MT Newswires Live
·
Jul 20

Scribe Therapeutics - IPO Price Expected Between $13 and $15 Per Share - SEC Filing

Reuters
·
Jul 20

Scribe Therapeutics Inc - Eli Lilly Has Indicated Interest in Purchasing Co's Shares of Common Stock at IPO Price

THOMSON REUTERS
·
Jul 20

AtaiBeckley downgraded to Hold from Buy at Berenberg

TIPRANKS
·
Jul 20

Almirall Says EMA Accepts Filing for Ebglyss Pediatric Use in Atopic Dermatitis

Reuters
·
Jul 20

Barclays Sticks to Its Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Jul 20

Analysts Are Bullish on These Healthcare Stocks: Tyra Bioscience (TYRA), Eli Lilly & Co (LLY)

TIPRANKS
·
Jul 19

AtaiBeckley downgraded to Hold from Buy at TD Cowen

TIPRANKS
·
Jul 18